Skip to content
ThermoMind logo — Next Generation Multimodal Screening Modality

ThermoMind

Next Generation Multimodal Screening Modality

Founded 2022 Israel Israel 5 employees Grant Total: $11.43M Health Care, Medical Devices

General Information

Company Name ThermoMind
Founded Year 2022
Location Israel Israel
Founders / Decision Makers
Team member
Employees 5
Industries Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ThermoMind. To contact ThermoMind, visit thermomind.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ThermoMind compare?

A PDF of ThermoMind and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ThermoMind soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ThermoMind

ThermoMind is a pioneering technology in the health care industry, founded in 2022 and based in Israel. The company's slogan, "Next Generation Multimodal Screening Modality," captures its core mission. ThermoMind's advanced approach combines Dynamic Multimodal Imaging and artificial intelligence to immediately detect and track biomarkers related to metabolic abnormalities caused by cancer cells. This innovative technology has recently attracted substantial investment, with a €11.43M grant investment received on 05 August 2022. The latest funding round signifies a strong endorsement of ThermoMind's potential to revolutionize cancer screening and diagnosis.

Business keywords: Medical Device, Diagnostic Device, Breast Cancer Detection, Infrared Imaging, Cancer Biomarkers, Early Cancer Detection, Women's Health, Telemedicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €11.43M -
05 Aug 2022

ThermoMind Alternatives & Competitors

View All Alternatives
ThermoMind vs

Breast Cancer Prediction Technology

Grant
21 employees
AI, Health Care
ThermoMind vs
Glooma
Glooma Portugal

Health. Care. Life.

Pre-Seed
12 employees
Health Care, Health and Wellness
ThermoMind vs
Seno Medical
Seno Medical United States

Groundbreaking diagnostic imaging for breast cancer using a novel combination of ultrasound and opto...

Series C
49 employees
Health Care, Medical Devices

FAQ About ThermoMind

Next Generation Multimodal Screening Modality
ThermoMind was founded in 2022.
ThermoMind is headquartered in Israel.
ThermoMind operates in Health Care and Medical Devices. Its work centres on Medical Device, Diagnostic Device, Breast Cancer Detection and Infrared Imaging.
ThermoMind has approximately 5 employees.
ThermoMind has completed 1 funding round, raising a total of $11.43M. The latest funding stage is Grant.
Top alternatives and competitors to ThermoMind include AILIS Care, Glooma, Seno Medical, Koning Health, MICA AI Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ThermoMind and AILIS Care are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ThermoMind, https://bouncewatch.com/company/thermomind, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout